Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
To collect baseline and outcome data relating to all bone marrow, peripheral blood, cord blood hematopoietic stem cell transplants and therapies related to hematopoietic stem cell transplantation performed in Queen Mary Hospital.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| All patients receiving allogeneic HSCT at Queen Mary Hospital, Hong Kong |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Overall survival | Time from HSCT to death or latest follow-up | 5 year |
| Relapse-free survival | Time from HSCT to relapse, death or latest follow-up | 5 years |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Adult patients aged 18 years or older who are undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT) at Queen Mary Hospital.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Harry HS Gill, MBBS, MD, FRCP, FRCPath | Contact | +852 22555859 | gillhsh@hku.hk |
| Name | Affiliation | Role |
|---|---|---|
| Harry HS Gill, MBBS, MD, FRCP, FRCPath | Department of Medicine, the University of Hong Kong | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Department of Medicine, Queen Mary Hospital | Recruiting | Hong Kong | Hong Kong |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 33623153 | Result | Passweg JR, Baldomero H, Chabannon C, Basak GW, de la Camara R, Corbacioglu S, Dolstra H, Duarte R, Glass B, Greco R, Lankester AC, Mohty M, Peffault de Latour R, Snowden JA, Yakoub-Agha I, Kroger N; European Society for Blood and Marrow Transplantation (EBMT). Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years. Bone Marrow Transplant. 2021 Jul;56(7):1651-1664. doi: 10.1038/s41409-021-01227-8. Epub 2021 Feb 23. | |
| 41954668 |
Not provided
Not provided
IPD will not be shared based on institutional policies.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Peripheral blood and bone marrow
| Queen Mary Hospital, Hong Kong | Recruiting | Hong Kong | Hong Kong |
| Derived |
| Leung GMK, Ye Y, Luo Y, Shi J, Zhao Y, Sim JPY, Kwong YL, He H, Gill H. A novel prognostic scoring system HATS for acute myeloid leukemia patients undergoing allogeneic hematopoietic stem cell transplantation. Ann Hematol. 2026 Apr 9;105(5):228. doi: 10.1007/s00277-026-06989-z. |